Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

News Post List

News digest – obesity and cancer, bacteria on skin, new immunotherapy targets and… vaping safety?

In the news this week: Bacteria might protect against skin cancer and worrying obesity projections for millennials.

Aggressive brain tumours carry potential target for engineered immune cells

A molecule on glioblastoma cells that could be used as a target for genetically engineered immune cells has been identified.

Does losing weight reduce the risk of cancer?

Obesity is the biggest cause of cancer in the UK, after smoking. We look at research trying to find out if losing weight can reduce your risk.

Millennials top obesity chart before reaching middle age

More than seven in 10 millennials – those born between the early 80s and mid 90s – are set to be overweight or obese between the ages of 35-44.

News digest – ‘mini tumours’, thyroid drugs, 100,000 Genomes Project, and… do superfoods prevent cancer?

'Mini tumours' to help guide treatment and NHS approval for three thyroid cancer drugs were in the news this week.

Three thyroid cancer drugs approved for NHS in England

Three thyroid cancer treatments have been approved for routine use on the NHS in England.

Precision drug could treat different cancers with rare gene fault  

A new targeted drug could be used to treat a small number of advanced cancers no matter where they grow in the body, according to new trial results.

Lab-grown ‘mini tumours’ could personalise cancer treatment

Testing cancer drugs on miniature replicas of a patient’s tumour could help doctors tailor treatment, according to new research.

Patients to benefit from new brain cancer research funding boost

Brain tumour research in the UK is set to be revolutionised with £45 million in funding by the Department of Health and Social Care and Cancer Research UK.

100,000 Genomes Project hits halfway milestone

An NHS research project to uncover the genetic causes of cancers and rare diseases has reached the halfway mark.

Pages